
 
 
 
 
 
 
 
 
   
   1 . A particle comprising:
 a first composition including a first polysaccharide in the form of a matrix and a viable  Escherichia coli  ( E. coli ), wherein the viable  E. coli  is embedded in the matrix, and wherein the first polysaccharide is a hydrocolloid-forming polysaccharide, and   a second composition free of the first polysaccharide, the second composition including a second polysaccharide and a disaccharide,   wherein the particle has a water activity (a w )≤0.3.   
 
     
   2 . The particle of  claim 1 , wherein the first polysaccharide includes alginate. 
 
     
   3 . The particle of  claim 1 , wherein 0.04≤a w ≤0.3. 
 
     
   4 . The particle of  claim 1 , wherein said second composition comprises a ratio disaccharide/second polysaccharide of less than 10, wherein the ratio is wt. %/wt. %. 
 
     
   5 . The particle of  claim 4 , wherein the ratio is of less than 5. 
 
     
   6 . The particle of  claim 4 , wherein the ratio is of about 1. 
 
     
   7 . The particle of  claim 1 , wherein said second composition further comprises a salt of L-glutamic acid. 
 
     
   8 . The particle of  claim 7 , wherein said salt is sodium salt of L-glutamic acid. 
 
     
   9 . The particle of  claim 1 , wherein said second polysaccharide includes maltodextrin. 
 
     
   10 . The particle of  claim 1 , wherein said second polysaccharide includes dextran. 
 
     
   11 . The particle of  claim 1 , wherein said  E. coli  includes a non-pathogenic  E. coli.    
 
     
   12 . The particle of  claim 1 , wherein said non-pathogenic  E. coli  includes the strain deposited at the International Depository Authority of Canada (IDAC) on Jan. 21, 2005, under accession number IDAC 210105-01. 
 
     
   13 . The particle of  claim 1 , wherein said non-pathogenic  E. coli  includes the strain deposited at the International Depository Authority of Canada (IDAC) on Jun. 20, 2013, and attributed accession number 200613-01. 
 
     
   14 . The particle of  claim 1 , wherein said hydrocolloid-forming polysaccharide is present in the matrix in percent by weight of total dry matter at a value of from 0.1% to 20%. 
 
     
   15 . The particle of  claim 1 , wherein said hydrocolloid-forming polysaccharide is present in the matrix in percent by weight of total dry matter at a value of from 1 to 12%. 
 
     
   16 . The particle of  claim 1 , wherein the first composition forms a core and the second composition is deposited on the core. 
 
     
   17 . The particle of  claim 1 , wherein said second polysaccharide is dextran and said disaccharide is sucrose, present in a ration dextran:sucrose of from 10:1 to 1:10. 
 
     
   18 . A particle comprising:
 a first composition including a first polysaccharide in the form of a matrix and a viable  Escherichia coli  ( E. coli ), wherein the viable  E. coli  is embedded in the matrix, and wherein the first polysaccharide is a hydrocolloid-forming polysaccharide, and   a second composition being different from the first composition, the second composition including a second polysaccharide and a disaccharide,   wherein the particle has a water activity (a w )≤0.3.   
 
     
   19 . The particle of  claim 18 , wherein the first polysaccharide includes alginate. 
 
     
   20 . The particle of  claim 18 , wherein 0.04≤a W ≤0.3. 
 
     
   21 . The particle of  claim 18 , wherein said second composition comprises a ratio disaccharide/second polysaccharide of less than 10, wherein the ratio is wt. %/wt. %. 
 
     
   22 . The particle of  claim 21 , wherein the ratio is of less than 5. 
 
     
   23 . The particle of  claim 21 , wherein the ratio is of about 1. 
 
     
   24 . The particle of  claim 18 , wherein said second composition further comprises a salt of L-glutamic acid. 
 
     
   25 . The particle of  claim 24 , wherein said salt is sodium salt of L-glutamic acid. 
 
     
   26 . The particle of  claim 18 , wherein said second polysaccharide includes maltodextrin. 
 
     
   27 . The particle of  claim 18 , wherein said second polysaccharide includes dextran. 
 
     
   28 . The particle of  claim 18 , wherein said  E. coli  includes a non-pathogenic  E. coli.    
 
     
   29 . The particle of  claim 18 , wherein said non-pathogenic  E. coli  includes the strain deposited at the International Depository Authority of Canada (IDAC) on Jan. 21, 2005, under accession number IDAC 210105-01. 
 
     
   30 . The particle of  claim 18 , wherein said non-pathogenic  E. coli  includes the strain deposited at the International Depository Authority of Canada (IDAC) on Jun. 20, 2013, and attributed accession number 200613-01. 
 
     
   31 . The particle of  claim 18 , wherein said hydrocolloid-forming polysaccharide is present in the matrix in percent by weight of total dry matter at a value of from 0.1% to 20%. 
 
     
   32 . The particle of  claim 18 , wherein said hydrocolloid-forming polysaccharide is present in the matrix in percent by weight of total dry matter at a value of from 1 to 12%. 
 
     
   33 . The particle of  claim 18 , wherein the first composition forms a core and the second composition is deposited on the core. 
 
     
   34 . The particle of  claim 18 , wherein said second polysaccharide is dextran and said disaccharide is sucrose, present in a ratio of dextran:sucrose of from 10:1 to 1:10. 
 
   
 
 
 
 
 
 
 
 
